Product features
Indirect chemiluminescent immunoassay (CLIA) to test IgG antibodies against Strongyloides stercoralis in human serum/plasma.
- Excellent sensitivity (94%) and specificity (93%)
- Adapted to urgent diagnosis - Rapid, automated protocol, results in around 1h
- No sample cumulation compared to the only existing ELISA’s in the market
- Full compatibility with the VirClia portfolio +90 assays
PRODUCTS
STRONGYLOIDES STERCORALIS VIRCLIA® IgG MONOTEST
USED ON
VirClia® Lotus
A compact automated CLIA platform for VirClia® infectious disease testing, combining ready-to-use single-test flexibility with continuous random access efficiency.
MORE RESOURCES
Downloadable PDF materials, brochures, and technical documents.
The latest insights, news, and research articles from our scientific team.
Polymicrobial Vaginal Infections: why third-party controls matter in molecular testing
Understanding the complexity of vaginal infectionsVaginal infections are among the most frequent reasons for gynecological consultation, but their dia...
Beyond detection: H. pylori testing in today’s laboratory workflow
Helicobacter pylori remains a highly relevant target in gastrointestinal diagnostics. It is a familiar pathogen, but its clinical importance has not d...
Aspergillus galactomannan: a practical biomarker for invasive aspergillosis diagnosis
Invasive aspergillosis is still one of the most difficult fungal infections to diagnose early. It mainly affects patients with weakened immune systems...
